Analysis of the application value and safety of donor renal biopsy during laparoscopic living donor nephrectomy
10.3760/cma.j.cn115396-20240704-00209
- VernacularTitle:腹腔镜活体供肾切取术中供肾穿刺活检的应用价值及安全性分析
- Author:
Guangpu DING
1
;
Jun LIN
;
Yichen ZHU
;
Jian ZHANG
Author Information
1. 首都医科大学附属北京友谊医院泌尿外科 北京市卫生健康委员会泌尿外科研究所，北京 100050
- Keywords:
Kidney transplantation;
Living donors;
Nephrectomy;
Biopsy
- From:
International Journal of Surgery
2024;51(10):671-676
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the application value and safety of donor renal biopsy during laparoscopic living donor nephrectomy.Methods:The clinical data of 45 pairs of living donor and recipients who underwent living kidney transplantation in Beijing Friendship Hospital, Capital Medical University from January 2023 to December 2023 were retrospectively analyzed. Remuzzi score was used to evaluate the renal biopsy pathology of the donor kidney. Recipients and donors were divided in different groups by donor age and Remuzzi score of the donor kidney biopsy. The clinical data, pathological data and renal function of the donors in different groups were compared. Shapiro-Wilk test was used to determine whether the data satisfied the normal distribution. The measurement data with normal distribution were expressed as mean±standard deviation ( ± s). The measurement data with non-normal distribution were expressed as median (interquartile range) [ M( Q1, Q3)], and comparison between groups was analyzed using the Mann-Whitney U test. Count data were expressed as the number of cases and percentage, and the Chi-square test or Fisher exact probability method was used for comparison between groups. Results:One recipient suffered from postoperative arteriovenous fistula, and the other living kidney transplant donors and recipients had no serious complications related to biopsy. Among the 45 cases of donor renal biopsy pathology, glomerular number was ≥20 in 36 cases (80.0%). There were 20 cases (44.4%, 20/45) in the high Remuzzi score group (≥4 points) and 25 cases (55.6%, 25/45) in the low Remuzzi score group (≤3 points). There were 17 cases (37.8%, 17/45) with IgA deposition and 1 case (2.2%, 1/45) with IgA nephropathy. There was no significant difference between the high Remuzzi score group and the low Remuzzi score group in terms of estimating glomerular filtration rate (eGFR) half year after surgery ( P> 0.05). 6 cases (13.3%, 6/45) in the elderly group (age ≥60 years) and 39 cases (86.7%, 39/45) in the young group (age< 60 years) had no significant difference in Remuzzi score, IgA deposition, IgA nephropathy, donor′s eGFR at discharge and recipient′s eGFR half a year after operation ( P> 0.05). Conclusions:Donor renal biopsy during laparoscopic living donor nephrectomy is a safe and effective way to evaluate donor kidney. The relationship between the results of abnormal donor kidney biopsy and the prognosis of donors and recipients is not clear, but the donors and recipients with abnormal donor kidney biopsy need to be followed up closely after operation.
